Search

everythinglearnresearchcommunity

for

Search:↓

People with androgenetic alopecia may have a higher risk of severe COVID-19.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Low-dose oral minoxidil alone is effective for treating hair loss, but combining it with dutasteride or finasteride may offer better results.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Certain hormone treatments can improve acne and related conditions in women.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Topical minoxidil and finasteride help treat male baldness, while women benefit from antiandrogens and minoxidil.

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Estrogen therapy helped regrow hair in a bald man.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Sex hormones and antiandrogens can either stimulate or inhibit human hair follicle cell growth depending on the dose.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Hair loss treatments for women are limited, with hair transplants being the only permanent option.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Antiandrogens can treat excess body hair and hair loss by blocking male hormones.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Hair loss improved with treatment and successful transplant.

Male-pattern baldness is a natural process with unclear causes, and while Minoxidil can help, the results often aren't satisfactory.

Finasteride, dutasteride, and oral minoxidil are effective for treating hair loss, with spironolactone as an option for women.

Dermatologists in Spain now mostly prescribe oral minoxidil and dutasteride for hair loss.

"Dread shed" is common with minoxidil but less so with other hair loss treatments.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.